Skip to main content
Log in

Age and disease-related changes in the mineral of bone

  • Session II
  • Published:
Calcified Tissue International Aims and scope Submit manuscript

Summary

Bone mineralization changes with age and disease. The distribution of mineral particles in a given bone (mineralization profile) has been studied using density fractionation as well as microradiography and electron backscattering imaging. The biological determinant of mineralization is the rate of turnover. During rapid growth and periods of high remodeling, mineralization is shifted towards lower mineral density (hypomineralization). During aging and periods of low remodeling, mineralization is shifted towards higher mineral densities (hypermineralization). Chemicals can also influence the mineralization profile of bone. Fluoride induces hypermineralization by stabilizing the apatite lattice and reducing bone mineral solubility, whereas strontium induces hypomineralization by loosening the apatite lattice and increasing bone mineral solubility. Drugs such as bisphosphonates induce hypermineralization by inhibiting resorption and acting as crystal poison. Finally, mineralization can be impaired by defects as in rickets and osteomalacia or made excessive by continuous accretion of mineral without resorption as in osteopetrosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Amprino E, Engstrom A (1952) Studies on X-ray absorption and diffraction of bone tissues. Acta Anat 15:1–22

    Google Scholar 

  2. Boyde A, Jones SJ (1983) Backscattered electron imaging of skeletal tissues. Metab Bone Dis Rel Res 5:145–150

    Google Scholar 

  3. Bonar LC, Roufosse AH, Sabine WK, Grynpas MD, Glimcher MJ (1983) X-ray diffraction studies of the crystallinity of bone mineral in newly synthesized and density fractionated bone. Calcif Tissue Int 35:202–203

    Google Scholar 

  4. Boskey AL, Marks SC Jr (1985) Mineral and matrix alterations in the bones of incisors-absent(ialia) osteopetrotic rats. Calcif Tissue Int 37:287–292

    Google Scholar 

  5. Grynpas MD, Hunter GK (1988) Bone mineral and glycosaminoglycans in newborn and mature rabbits. J Bone Miner Res 3:159–164

    Google Scholar 

  6. Martin RB, Pickett JC, Zinaich S (1980) Studies of skeletal remodelling in aging men. Clin Orthop Rel Res 149:268–282

    Google Scholar 

  7. Laval-Jeantet A, Bergot C, Carroll R, Garcia-Schaefer F (1983) Cortical bone senescence and mineral bone density of the humerus. Calcif Tissue Int 35:268–272

    Google Scholar 

  8. Lindhal O, Lindgarden AGH (1967) Cortical bone in man. Acta Orthop Scand 38:133–140

    Google Scholar 

  9. Thompson DD (1980) Age changes in bone mineralization, cortical thickness, and haversian canal area. Calcif Tissue Int 31:5–11

    Google Scholar 

  10. Dequeker J (1975) Bone and aging. Ann Rheum Dis 34:100-115 11. Sharpe WD (1979) Age changes in human bone: an overview. Bull NY Acad Med 55:757–773

    Google Scholar 

  11. Joswey J, Reiss E, Canterbury JM (1974) Long-term effect of high phosphate intake on parathyroid hormone levels and bone metabolism. Acta Orthop Scand 45:801–808

    Google Scholar 

  12. Barbos MP, Bianco P, Ascenzi A (1983) Distribution of osteonic and interstitial components in the human femoral shaft with reference to structure, calcification and mechanical properties. Acta Anat 115:178–186

    Google Scholar 

  13. Pankovich AM, Simmons DJ, Kilkarni VV (1974) Zonal osteons in cortical bone. Clin Orthop Rel Res 100:356–363

    Google Scholar 

  14. Trotter M, Dickson BB (1974) Sequential changes in weight, density, and percentage ash weight of human skeletons from an early fetal period through old age. Anat Rec 179:118

    Google Scholar 

  15. Lacroix P, Dhem A (1967) Le Vieillisement des Os Belge. Orthop 33:745–760

    Google Scholar 

  16. Atkinson PJ (1969) Structural aspects of aging bone. Gerontologia 15:171–173

    Google Scholar 

  17. Riggs BL, Seeman E, Hodgson SF, Taves DR, O'Flannon WM (1982) Effect of osteoporosis. N Engl J Med 8:446–450

    Google Scholar 

  18. Mazess RB (1982) On aging bone loss. Clin Orthop Rel Res 165:239–252

    Google Scholar 

  19. Phillips HB, Owen-James S, Chandler B (1978) Quantitative histology of bone: a computerized method of measuring the total mineral content of bone. Calcif Tissue Res 26:85–89

    Google Scholar 

  20. Pugliese LR, Anderson C (1986) A method for the determination of the relative distribution and relative quantity of mineral in bone sections. J Histotechnology 9:91–93

    Google Scholar 

  21. Reid SA, Boyde A (1987) Changes in the mineral density distribution in human bone with age: image analysis using backscattered electrons in the SEM. J Bone Miner Res 2:13–22

    Google Scholar 

  22. Boyce TM, Bloebaum RD, Bachus KN, Skedros JG (1990) Reproducible method for calibrating the backscattered signal for quantitative assessment of mineral content in bone. Scanning Microsc 4:591–603

    Google Scholar 

  23. Simmons ED, Pritzker KPH, Grynpas MD (1991) Age-related changes in human cortical bone. J Orthop Res 9(2):155–167

    Google Scholar 

  24. Glimcher MJ (1976) The composition, structure, and organization of bone and other mineralized tissue and the mechanisms of calcification. In: Grrep RO, Astwood EB (eds) Handbook of physiology: endocrinology, vol. 7. Am Phys Soc, Washington DC, pp 25–113

    Google Scholar 

  25. Robinson AA (1952) An electron microscope study of the crystalline inorganic component of bone and its relationship to the organic matrix. J Bone Joint Surg 34A:389–434

    Google Scholar 

  26. Richell LJ (1967) Contribution à L'étude du Mètabolisme Mineral de l'os Chez le Rat. PhD Thesis, University of Liège, Liège

    Google Scholar 

  27. Albright F, Reifenstein EC (1948) The parathyroid glands and metabolic bone disease. Williams and Wilkins (ed). Baltimore, MD, p 393

  28. Frost HM (1985) The pathomechanics of osteoporoses. Clin Orthop Rel Res 200:198–225

    Google Scholar 

  29. Parfitt AM (1981) Bone remodelling in the pathogenesis of osteoporosis. Res Staff Phys Dec.:60–66, 71–72

    Google Scholar 

  30. Heaney RP (1992) The natural history of vertebral osteoporosis. Is low bone mass an epiphenomenon? Bone 13:S23-S26.

    Google Scholar 

  31. Heaney RP, Avioli LV, Chesnut C II, Brandenburger GH, Lappe J, Recker RR (1989) Osteoporotic bone fragility. Detection by ultrasound transmission velocity. JAMA 261:2986–2990

    Google Scholar 

  32. Melton LJ II, Kan SH, Frye MA, Wahner HW, O'Fallon WM, Riggs BL (1989) Epidemiology of vertebral fractures in women. Am J Epidemiol 129:1000–1011

    Google Scholar 

  33. Chantraine A, Nusgens B, Lapiere ChM (1986) Bone remodelling during the development of osteoporosis in paraplegia. Calcif Tissue Int 38:323–327

    Google Scholar 

  34. Grynpas MD, Alpert B, Lieberman I, Katz I, Pritzker KPH (1991) Subchondral bone in osteoarthritis. Calcif Tissue Int 49:20–26

    Google Scholar 

  35. Utoff HK, Jaworski ZFG (1978) Bone loss in response to longterm immobilization. J Bone Joint Surg 60(B):420–429

    Google Scholar 

  36. Burkhart JM, Jowsey J (1967) Parathyroid and thyroid hormones in the development of immobilization osteoporosis. Endocrinology 81:1053–1062

    Google Scholar 

  37. Wronski TJ, Yen C-F (1991) The ovariectomized rat as an animal model for postmenopausal bone loss. Cells Material (suppl) 1:69–75

    Google Scholar 

  38. Kimmel DB (1991) The oophorectomized beagle as an experimental model for estrogen-depletion bone loss in the adult human. (suppl) Cells Materials 1:75

    Google Scholar 

  39. Whiting SJ, Draper H (1980) The role of sulfate in the calcuria of high protein diets in adult rats. J Nutrition 110:212–222

    Google Scholar 

  40. Barzel US (1975) Studies on osteoporosis: the long-term effect of oophorectomy and of ammonium chloride ingestion on the bone of mature rats. Endocrinology 96:1304–1306

    Google Scholar 

  41. Bressot C, Coupron P, Edouard C, Meurnier P (1976) Histomorphometrie des Osteophaties Endocriniennes, Ph.D. Thesis, Lyon, France

  42. Thompson R (1973) Heparin osteoporosis. J Bone Joint Surg 55A(3):606–612

    Google Scholar 

  43. Bauss F, Minne HW, Sterz H, Weng V, Wesh H, Ziegler R (1985) Comparative bone analysis via inflammation-mediated osteopenia in the rat. Calcif Tissue Int 37:539–546

    Google Scholar 

  44. Dickson IR, Kodicek E (1979) Effect of vitamin D deficiency on bone formation in the chick. Biochem J 182:429–435

    Google Scholar 

  45. Aitken JM (1976) Factors affecting the distribution of zinc in the human skeleton. Calcif Tissue Res 20:23–30

    Google Scholar 

  46. Lei KY, Young LC (1978) Mineral content of bone and other tissues. In: Bowden DM (ed) Aging in nonhuman primates. Van Nostrand, New York, pp 348–355

    Google Scholar 

  47. Burnell JM, Baylink DJ, Chesnut CH, Tuebner E (1986) The role of skeletal caclium deficiency in postmenopausal osteoporosis. Calcif Tissue Int 38:187–192

    Google Scholar 

  48. Harrison JE, Bayley TA, Josse RG, Murray TM, Sturtridge W, Williams C, Goodwing S, Tam C, Fornasier V (1986) The relationship between fluoride effects on bone histology and on bone mass in patients with postmenopausal osteoporosis. Bone Miner 1:321–333

    Google Scholar 

  49. Grynpas MD, Marie P (1990) Low doses of stable strontium alter the quality and quantity of bone in rats. Bone 11:313–319

    Google Scholar 

  50. Posner AS, Eanes ED, Harper RA (1963) X-ray diffraction analysis of the effect of fluoride on human bone apatite. Arch Oral Biol 8:549–570

    Google Scholar 

  51. Grynpas MD, Pritzker KPH, Simmons ED, Hancock RGV, Harrison JE (1986) In: Ali Y (ed) Is fluoridated bone different from non-fluoridated bone? Cell-mediated calcification and matrix vesicles. Elsevier Science, New York, pp 409–414

    Google Scholar 

  52. Grynpas MD, Cheng P-T (1988) Fluoride reduces the rate of dissolution of bone. Bone Miner 5:1–9

    Google Scholar 

  53. Ericsson Y, Ekberg O (1975) Dietetically provoked general alveolar osteopenia in rat and its prevention or cure by calcium and fluoride. J Periodont Res 10:256–269

    Google Scholar 

  54. Bang S (1978) Effects of fluoride on the chemical composition of inorganic bone substance. In: Courvoisier B, Donath A, Baud CA (eds) Hans Huber, Bern, pp 56–61

    Google Scholar 

  55. Turner CH, Akhter MP, Heaney RP (1992) The effects of fluoridated water on bone strength. J Orthop Res 10:581–587

    Google Scholar 

  56. Legeros RZ, Quirologico G, Legeros JP (1979) Incorporation of strontium in apatite: effect of pH. J Dent Res 58(A):169

    Google Scholar 

  57. Skornya SC (1981) Effects of oral supplementation with stable strontium. Can Med Assoc J 125:703–712

    Google Scholar 

  58. Skornya SC (1984) Metabolic aspects of the pharmacologic use of trace elements in human subjects with specific reference to stable strontium. Trace Subst Environ Health 18:3–23

    Google Scholar 

  59. Marie PJ, Garba MT, Hott M, Miravet L (1985a) Effect of low doses of stable strontium on bone metabolism in rats. Miner Electrolyte Metab 11:5–13

    Google Scholar 

  60. Marie PJ, Hott M, Garba MT (1985b) Contrasting effect in 1.25-dihydroxyvitamin D3 on bone matrix and mineral appositional rates in the mouse. Metabolism 34(8):777–783

    Google Scholar 

  61. Matsumoto A (1976) Effect of strontium on the epiphyseal cartilage plate of rat tibiae. Jpn J Pharmacol 26:675–681

    Google Scholar 

  62. Johnson AR (1973) The influence of strontium on characteristic factors of bone. Calcif Tissue Res 11:215–221

    Google Scholar 

  63. Ott SM, Maloney NA, Coburn JW, Algrey AC, Sherrard DJ (1982) The prevalence of bone aluminum deposition in renal osteodystrophy and its relation to the response to calcitriol therapy. N Engl J Med 307:136

    Google Scholar 

  64. Blumenthal NC, Posner AS (1984) In vitro model of aluminum-induced osteomalacia: inhibition of hydroxyapatite formation and growth. Calcif Tissue Int 36:439

    Google Scholar 

  65. Francis MD, Martodam RR (1983) Chemical, biochemical and medicinal properties of the diphosphonates. In: Hildebrand RL (ed) The role of phosphonates in living systems. Boca Raton, CRC Press, pp 55–96

    Google Scholar 

  66. Jung A, Bisaz S, Bartholdi P, Fleisch H (1973) Influence of pyrophosphate on the exchange of calcium and phosphate ions on hydroxyapatite. Calcif Tissue Res 13:27–40

    Google Scholar 

  67. Shinoda H, Adamek G, Felix R, Fleisch H, Schenk R, Hagan P (1983) Structure-activity relationship of various biphosphates. Calcif Tissue Int 35:87–89

    Google Scholar 

  68. Riggs BL, Wahner HW, Seeman E, Offord KP, Dunn WL, Mazess RB, Johnson KA, Melton LJ (1982) Changes in bone mineral density of the proximal femur and spine with aging. J Clin Invest 70:716–723

    Google Scholar 

  69. Grynpas MD (1989) Bone quality and quantity. Future Health 11(1):7–8

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Grynpas, M. Age and disease-related changes in the mineral of bone. Calcif Tissue Int 53 (Suppl 1), S57–S64 (1993). https://doi.org/10.1007/BF01673403

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01673403

Key words

Navigation